Prevalence, severity, and distribution of depression and anxiety symptoms are examined before and nine months after the COVID-19 pandemic, highlighting the need for continued monitoring and targeted interventions to address mental health challenges in affected populations.
March 2022
Inactivated SARS-CoV-2 vaccine (CoronaVac) is well tolerated and induces humoral responses in children, supporting its safety and immunogenicity profile in pediatric populations, with implications for COVID-19 vaccination strategies and public health policies.
March 2022
American Heart Association and American Stroke Association issue a statement on the role of primary care physicians in patient follow-up after stroke, emphasizing the importance of coordinated care and secondary prevention strategies to optimize long-term outcomes.
March 2022
Acute liver failure is a rare syndrome primarily associated with paracetamol overdose toxicity, highlighting the need for early recognition, prompt intervention, and supportive care to improve patient outcomes.
March 2022
Greater trunk flexion significantly impacts stride length, joint movements, and ground reaction forces during running, underscoring the importance of biomechanical considerations in injury prevention strategies for runners.
March 2022
Evolution of gastrectomy for cancer over the past 30 years is examined to identify potential areas for further improvements and research topics, informing future developments in surgical techniques and perioperative care to enhance patient outcomes in gastric cancer treatment.
March 2022
Review discusses measurement considerations, guideline recommendations, and emerging therapies for lipoprotein (a) in the management of cardiovascular diseases, highlighting the importance of risk assessment and targeted interventions to reduce cardiovascular morbidity and mortality.
March 2022
Argentine investigation published in Cell Reports Medicine demonstrates that the Sputnik V vaccine induces seroconversion and neutralizing capacity, contributing to the growing body of evidence supporting the safety and efficacy of this COVID-19 vaccine candidate.
March 2022
Olfactory support cells, rather than neurons, are vulnerable to infection by SARS-CoV-2, contributing to olfactory dysfunction in COVID-19 patients and highlighting potential targets for therapeutic interventions.
March 2022